DecisionPoint Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
DecisionPoint Financial's VRTX Position: Q2 2026 in Review
DecisionPoint Financial reduced its Vertex Pharmaceuticals (VRTX) stake by 80% in Q2 2026, selling an estimated $3.54K and leaving 2 shares worth $997. The position accounts for ﹤0.01% of the portfolio, ranked #448.
DecisionPoint Financial first reported a position in VRTX in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.47K in Q1 2026. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- DecisionPoint Financial held 2 shares of Vertex Pharmaceuticals worth $997 as of Q2 2026.
- DecisionPoint Financial sold 8 Vertex Pharmaceuticals shares in Q2 2026, an estimated $3.54K.
- Vertex Pharmaceuticals made up ﹤0.01% of DecisionPoint Financial's portfolio in Q2 2026, its #448 holding.
- DecisionPoint Financial first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
- DecisionPoint Financial's Vertex Pharmaceuticals position peaked at $4.47K in Q1 2026.
- 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on DecisionPoint Financial's 13F filing for Q2 2026, filed 5 Aug 2026.